Delivery Order SPE2DB22D2005-SPE2DB25FJQB5
- Not listed
- The Defense Logistics Agency (DLA) awarded a firm-fixed-price delivery order contract to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of DEXCOM G6 SENSOR 3S medical devices. The contract has a ceiling value of $2,719.26 and an ultimate completion date of October 17, 2024. This delivery order is part of a larger Indefinite Delivery Contract (IDC) between AmerisourceBergen and the DLA Troop Support Medical, valued at $999,999,999 and running through November...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp for the supply of DEXCOM G6 SENSOR 3S medical devices. The delivery order has a ceiling value of $40,474.71 and a completion date of September 10, 2024. It is issued under a larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at up to $999,999,999 through December 2025, which enables the agency to procure a comprehensive range of...
- The Defense Logistics Agency (DLA) awarded a firm-fixed-price delivery order to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation, for the provision of DEXCOM G6 SENSORS 3S. This $3,304.58 contract has an ultimate completion date of April 10, 2024 and is not associated with any set-aside designation. AmerisourceBergen Drug Corp also holds an indefinite delivery contract (IDC) with DLA, valued at up to $999,999,999.00 through December 31, 2025. This IDC serves as the...
- The Defense Logistics Agency awarded a $1,261 delivery order to Amerisourcebergen Drug Corporation for Dexcom G6 sensors. The firm fixed price order is for a one day period of performance from July 5-6, 2023 in Conshohocken, Pennsylvania. As a major distributor of medical supplies to the Department of Defense, Amerisourcebergen will deliver the continuous glucose monitoring devices in support of DLA's provision of critical healthcare materials. No subcontractors or set aside designations were...
- The Defense Logistics Agency awarded a $2,507 firm fixed price delivery order to Amerisourcebergen Drug Corporation for DEXCOM G6 Sensors. The delivery order is being performed in Conshohocken, Pennsylvania through August 31, 2023. As a leading supplier of medical and surgical supplies to the Department of Defense, Amerisourcebergen will deliver DEXCOM continuous glucose monitoring sensors in support of the Defense Logistics Agency's provision of critical medical equipment. No subcontractors...
- The U.S. Defense Logistics Agency (DLA) awarded a delivery order contract valued at $5,262.32 to Amerisourcebergen Drug Corp's Corporate Office division, a major pharmaceutical distributor. The contract is for the delivery of DEXCOM G6 SENSOR 3S medical devices, with a period of performance ending on June 25, 2024. This award is part of a larger Indefinite Delivery Contract (IDC) that Amerisourcebergen holds with DLA Troop Support Medical, valued up to $999,999,999.00 through December 31,...
- The Defense Logistics Agency awarded a $4,551.56 firm fixed price delivery order to Amerisourcebergen Drug Corp Corporate Office Division for DEXCOM G6 SENSOR 3S. The order is for medical supplies to be delivered to a facility in Conshohocken, Pennsylvania by June 27, 2023 in support of DOD programs. Amerisourcebergen will provide Dexcom G6 sensors, a type of continuous glucose monitor, as the prime contractor. Funding comes from the Defense Logistics Agency, which maintains readiness by...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $3,591.93, is for the procurement of DEXCOM G7 SENSORS, a type of continuous glucose monitoring device. The contract has a firm fixed price pricing type and an ultimate completion date of November 26, 2024. This delivery order is part of a larger $999,999,999 Indefinite...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of DEXCOM G6 SENSOR 3S medical devices. The order is valued at $25,020.32 and has a completion date of November 2, 2023. The contract is a firm-fixed-price delivery order, and no set-aside designation was used. AmerisourceBergen Drug Corp is a subsidiary of the parent company Cencora, Inc., which holds a significant...
- The Defense Logistics Agency awarded a $4,406.30 firm fixed price delivery order to Amerisourcebergen Drug Corporation for Dexcom G6 sensors. As the prime contractor, Amerisourcebergen will supply the continuous glucose monitoring devices to support the Department of Defense's medical logistics needs. The single day period of performance from August 24-25, 2023 indicates this is a small order under the DLA's prime vendor contract vehicle. No set aside provisions or subcontractors were...
- SPE2DB22D2005Indefinite Delivery Contract
- SPE2DB22D2005-SPE2DB25FJQB5Delivery Order
The Defense Logistics Agency (DLA) awarded a $4,419.80 delivery order to AmerisourceBergen Drug Corp for Dexcom G6 Sensor 3S continuous glucose monitoring devices on July 18, 2025, with an ultimate completion date of July 21, 2025. This firm fixed-price delivery order was competitively awarded with no set-aside designation and represents a continuation of the vendor's extensive role in supporting federal medical supply needs. The supplies will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order falls under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. As a major pharmaceutical distributor and critical federal medical procurement vendor, AmerisourceBergen supplies comprehensive medical commodities including brand-name and generic medications, vaccines, medical devices, and specialized healthcare supplies to military and veteran healthcare systems. The Dexcom glucose monitoring sensors align with the company's established portfolio of chronic disease management products delivered through the DLA's global pharmaceutical support framework, which serves the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $4.4k | 7/18/25 |